"Health Canada Greenlights Pfizer's RSV Vaccine, Promising Broad Protection for Infants and Older Adults"
A new study suggests that if Respiratory Syncytial Virus (RSV) vaccines were distributed similarly to annual flu shots, deaths from the virus could be significantly reduced. The study highlights the potential impact of widespread RSV vaccination on public health, particularly for vulnerable populations such as young children and the elderly, who are most at risk from the virus.